首页> 美国政府科技报告 >Consolidated Guidance About Materials Licenses. Program-Specific Guidance About Commercial Radiopharmacy Licenses
【24h】

Consolidated Guidance About Materials Licenses. Program-Specific Guidance About Commercial Radiopharmacy Licenses

机译:关于商业放射性药物许可证的计划特定指南

获取原文

摘要

On August 8, 2005, the Energy Policy Act of 2005 (EPAct) gave NRC new regulatory authority over additional by product material. This new by product material now also includes naturally occurring materials, such as discrete sources of Radium-226, and accelerator-produced radioactive materials (NARM). This revision of NUREG-1556, Vol. 13, adds guidance needed to license commercial radio pharmacies as a result of the regulatory changes made by the EPAct and the NARM rule, Requirements for Expanded Definition of By product Material. This guidance document contains information that is intended to assist applicants for commercial radiopharmacy licenses in preparing their license applications. In particular, it describes the type of information needed to complete NRC Form 313, Application for Materials License. This document both describes the methods acceptable to NRC license reviewers in implementing the regulations and the techniques used by the reviewers in evaluating the application to determine if the proposed activities are acceptable for licensing purposes.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号